Integrated exposure and nose modeling and analysis system .1. Formulation and testing of microenvironmental and pharmacokinetic components

被引:17
作者
Georgopoulos, PG [1 ]
Walia, A [1 ]
Roy, A [1 ]
Lioy, PJ [1 ]
机构
[1] UNIV MED & DENT NEW JERSEY,PISCATAWAY,NJ 08855
关键词
VOLATILE ORGANIC-COMPOUNDS; INDOOR AIR; METHOTREXATE PHARMACOKINETICS; DERMAL ABSORPTION; HUMAN-LUNG; TRANSPORT; WATER; OZONE; CONTAMINANTS; POLLUTANTS;
D O I
10.1021/es950764s
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
The conceptual and theoretical framework for a modular integrated Exposure and Dose Modeling and Analysis System (EDMAS) has been formulated, and its stepwise implementation and testing is currently in progress. This system aims to provide state-of-the-art tools for performing integrated assessments of exposure and dose for individuals and populations. The integration of modeling components with each other as well as with available environmental, exposure, and toxicological databases is being accomplished with the use of computational toots that include interactive simulation environments, Geographical Information Systems, and various data retrieval, management, statistical analysis, and visualization methods. This paper overviews the structure and modular nature of this integrated modeling system and focuses specifically on two of its components: (a) a hierarchy of physiologically based pharmacokinetic models (PBPKM), representing Various levels of detail and sophistication, and (b) a family of microenvironmental models, that incorporate complex physical and chemical transformations. The deterministic implementation of these components is also presented here in two test applications: (i) a case study of benzene exposure indoors resulting from the volatilization of contaminated tap water and (ii) a case study of photochemical pollution infiltration indoors, in an office building environment.
引用
收藏
页码:17 / 27
页数:11
相关论文
共 77 条
[1]  
ADAMS WC, 1993, TECHNICAL REPORT CAL
[2]  
*ADV VIS SYST INC, 1992, AVS APPL VIS SYST
[3]  
ANDELMAN JB, VIP16 AWMA US EPA, P300
[4]   PHYSIOLOGICAL MODELING OF ORGANIC-COMPOUNDS [J].
ANDERSEN, ME .
ANNALS OF OCCUPATIONAL HYGIENE, 1991, 35 (03) :309-321
[5]   PHYSIOLOGICALLY BASED PHARMACOKINETICS AND THE RISK ASSESSMENT PROCESS FOR METHYLENE-CHLORIDE [J].
ANDERSEN, ME ;
CLEWELL, HJ ;
GARGAS, ML ;
SMITH, FA ;
REITZ, RH .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1987, 87 (02) :185-205
[6]  
[Anonymous], EPA600891011B OFF RE
[7]  
AXLEY JW, 1993, AM SOC TEST MATER, V1205, P105, DOI 10.1520/STP13102S
[8]  
BEHAV JV, 1989, VIP16 AWMA US EPA, P436
[9]  
Bischoff K., 1966, Chem. Eng. Progr. Syrup. Ser, V62, P32
[10]   METHOTREXATE PHARMACOKINETICS [J].
BISCHOFF, KB ;
DEDRICK, RL ;
ZAHARKO, DS ;
LONGSTRETH, JA .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (08) :1128-+